Global COVID-19 prevention trial of hydroxychloroquine to resume

It is a randomised, placebo-controlled trial that is aiming to enrol 40,000 healthcare workers and other at-risk staff around the world, and is being led by the Oxford University's Mahidol Oxford Tropical Medicine Research Unit in the Thai capital, Bangkok

from Livemint - Science https://ift.tt/2CUUQ5D